.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Moodys
Cantor Fitzgerald
McKesson
Federal Trade Commission
Novartis
Dow
Johnson and Johnson
Fuji
Daiichi Sankyo

Generated: November 22, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: deferoxamine mesylate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Fresenius Kabi Usa
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION078718ANDAFresenius Kabi USA, LLC63323-597-101 VIAL in 1 BOX (63323-597-10) > 5.3 mL in 1 VIAL
Fresenius Kabi Usa
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION078718ANDAFresenius Kabi USA, LLC63323-599-301 VIAL in 1 BOX (63323-599-30) > 21.1 mL in 1 VIAL
Hospira
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076019ANDAHospira, Inc.0409-2336-104 VIAL, SINGLE-USE in 1 CARTON (0409-2336-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Hospira
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076019ANDAHospira, Inc.0409-2336-1310 VIAL, SINGLE-USE in 1 CARTON (0409-2336-13) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Hospira
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076019ANDAHospira, Inc.0409-2337-254 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Hospira
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION076019ANDAHospira, Inc.0409-2337-1210 VIAL, SINGLE-USE in 1 CARTON (0409-2337-12) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE
Novartis
DESFERAL
deferoxamine mesylate
INJECTABLE;INJECTION016267NDANovartis Pharmaceuticals Corporation0078-0467-914 VIAL in 1 CARTON (0078-0467-91) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61)
Gland Pharma Ltd
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION207384ANDAGland Pharma Limited68083-172-014 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-172-01)
Gland Pharma Ltd
DEFEROXAMINE MESYLATE
deferoxamine mesylate
INJECTABLE;INJECTION207384ANDAGland Pharma Limited68083-173-014 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (68083-173-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Harvard Business School
Queensland Health
Colorcon
US Department of Justice
Julphar
Accenture
Chubb
Cantor Fitzgerald
Merck

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot